CLINICAL_TRIALS
trial_result
· 2015-07-22
Clinical Trial Update: Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer [NA]
Summary
A completed clinical trial investigating docetaxel with androgen deprivation and proton therapy for high-risk prostate cancer; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2015-07-22